Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$9.68 +0.09 (+0.89%)
As of: Nov 12, 2026 · 12:16 PM EST

Syndax Pharmaceuticals (SNDX) Interest & Investment Income (2019 - 2026)

Updated

Syndax Pharmaceuticals' Interest & Investment Income was $5.59 million in Q3 2026, up 6.1% from $5.27 million a year earlier and up 49.3% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Interest & Investment Income (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Syndax Pharmaceuticals' Interest & Investment Income was $17.23 million through Sep 30, 2026, down 32.5% year-over-year; for FY2025, it was $22.73 million, down 12.9% from FY2024.

  • Interest & Investment Income shows a five-year compound annual growth rate of 93.4% (FY2020 to FY2025).
  • In earlier years, Interest & Investment Income was $26.09 million in FY2024 (+23.3%), $21.16 million in FY2023 (+260.4%), $5.87 million in FY2022 and $403,000 in FY2021 (-52.1%).
  • The Q3 2026 figure marks the highest quarterly Interest & Investment Income since Q2 2025.
  • Compared with a year earlier, Interest & Investment Income was higher in two of the last eight quarters, with an average decline of 12.7%.
  • The best year-over-year quarter for Interest & Investment Income over five years was Q2 2022 (growth of 713.0%); the worst was Q1 2026 (a decline of 50.4%).
  • Per Business Quant data, SNDX's Interest & Investment Income in the three quarters before Q3 2026 was $3.75 million (Q2 2026), $3.56 million (Q1 2026) and $4.33 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 186.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Syndax Pharmaceuticals 854.00 Mn -867.10 Mn 69.30 Mn 5.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.59 Mn
Jun 30, 2026 3.75 Mn
Mar 31, 2026 3.56 Mn
Dec 31, 2025 4.33 Mn
Sep 30, 2025 5.27 Mn
Jun 30, 2025 5.95 Mn
Mar 31, 2025 7.18 Mn
Dec 31, 2024 7.11 Mn
Sep 30, 2024 5.44 Mn
Jun 30, 2024 6.28 Mn
Mar 31, 2024 7.26 Mn
Dec 31, 2023 5.55 Mn
Sep 30, 2023 5.35 Mn
Jun 30, 2023 5.19 Mn
Mar 31, 2023 5.08 Mn
Dec 31, 2022 2.99 Mn
Sep 30, 2022 1.78 Mn
Jun 30, 2022 878,000.00
Mar 31, 2022 224,000.00
Dec 31, 2021 91,000.00
API Access

Syndax Pharmaceuticals Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SNDX&period=max&api_key=YOUR_API_KEY